Perlara

https://www.ycombinator.com/companies/perlara

Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech

About
  • Year Founded: 2014
  • Number of Founders: 1
  • HQ: San Francisco, California, United States
  • Domain: perlara.com
  • Email: info@perlara.com
  • Industries: Biotechnology, Genetics, Pharmaceutical, Therapeutics, Medical
  • Total Funding: 11763002
  • Number of Funding Rounds: 6.0
  • Last Funding Round Type: Series A
  • Last Funding Date: 2017-08-18
  • Team Size: 1
  • Founder Names: Ethan Perlstein
Related Companies
BEST COMPANIES IN W16
SIMILAR YC COMPANIES
Contacts